Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,435.98
(
-0.79%
)
News Focus
News Focus
Post# of 257579
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

masterlongevity

Send PM Follow Ignore
Followers 24
Posts 2597
Boards Moderated 0
Alias Born 01/07/2004

masterlongevity

Re: DewDiligence post# 67588

Tuesday, 10/21/2008 6:20:07 PM

Tuesday, October 21, 2008 6:20:07 PM

Post# of 257579
did you see the crohn's sales?

only 200 crohn's pts to date have been treated with tysabri.


also, question...

would be interested to see what the new market share numbers are for MS market. Avonex seems to be growing nicely and tysabri is growing a little. is the overrall market growing dramatically or is the market share for one of the other therapies decreasing?
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today